<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>在承认错误之后，阿斯利康面临着有关其疫苗的难题After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine<br/>在承认错误之后，阿斯利康面临着有关其疫苗的难题</h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2020-11-26 07:29:29</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2020/11/aebe61ea78b91de2f79c0adb46234328.jpg"><img src="http://img2.diglog.com/img/2020/11/aebe61ea78b91de2f79c0adb46234328.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>The announcement this week that a cheap, easy-to-make coronavirus vaccine  appeared to be up to 90 percent effective was greeted with jubilation. “Get yourself a vaccaccino,”  a British tabloid celebrated, noting that the vaccine, developed by AstraZeneca and the University of Oxford, costs less than a cup of coffee.</p><p>本周宣布的一种廉价，易于制作的冠状病毒疫苗似乎可以达到90％的有效效果令人们欢欣鼓舞。一位英国小报庆祝说：“给自己注射疫苗，”他指出，这种疫苗是由阿斯利康和牛津大学开发的，价格不到一杯咖啡。</p><p> But since unveiling the preliminary results, AstraZeneca has acknowledged a key mistake in the vaccine dosage received by some study participants, adding to questions about whether the vaccine’s apparently spectacular efficacy will hold up under additional testing.</p><p> 但是，自公布初步结果以来，阿斯利康已经承认一些研究参与者所接受的疫苗剂量存在关键错误，这增加了人们对该疫苗明显的功效是否会在额外的测试中保持下去的疑问。</p><p> Scientists and industry experts said the error and a  series of other irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.</p><p> 科学家和行业专家表示，阿斯利康最初披露数据的方式存在错误以及一系列其他不规则和遗漏，削弱了他们对结果可靠性的信心。</p><p> Officials in the United States have noted that the results were not clear. It was the head of the flagship federal vaccine initiative — not the company — who first disclosed that the vaccine’s most promising results did not reflect data from older people.</p><p> 美国官员指出，结果尚不清楚。它是旗舰联邦疫苗计划的负责人而不是公司的负责人，他首先透露该疫苗最有希望的结果并未反映出老年人的数据。</p><p> The upshot, the experts said, is that the odds of regulators in the United States and elsewhere quickly authorizing the emergency use of the AstraZeneca vaccine are declining, an unexpected setback in the global campaign to corral the devastating pandemic.</p><p> 专家们说，结果是，美国和其他地方的监管机构迅速授权紧急使用阿斯利康疫苗的可能性正在下降，这是遏制毁灭性大流行的全球运动的意外挫折。</p><p> “I think that they have really damaged confidence in their whole development program,” said Geoffrey Porges, an analyst for the investment bank SVB Leerink.</p><p> 投资银行SVB Leerink的分析师Geoffrey Porges说：“我认为他们确实损害了他们对整个开发计划的信心。”</p><p> Michele Meixell, a spokeswoman for AstraZeneca, said the trials “were conducted to the highest standards.”</p><p> 阿斯利康（AstraZeneca）的发言人米歇尔·梅克塞尔（Michele Meixell）表示，这些试验“是按照最高标准进行的。”</p><p> In an interview on Wednesday, Menelas Pangalos, the AstraZeneca executive in charge of much of the company’s research and development, defended the company’s handling of the testing and its public disclosures. He said the error in the dosage was made by a contractor, and that, once it was discovered, regulators were immediately notified and signed off on the plan to continue testing the vaccine in different doses.</p><p>在周三的一次采访中，负责公司大部分研发工作的阿斯利康高管梅内拉斯·潘加洛斯（Menelas Pangalos）为公司处理测试和公开披露的行为辩护。他说，剂量错误是由承包商造成的，一旦发现错误，便会立即通知监管者并签署计划，继续测试不同剂量的疫苗。</p><p> Asked why AstraZeneca shared some information with Wall Street analysts and some other officials and experts but not with the public, he responded, “I think the best way of reflecting the results is in a peer-reviewed scientific journal, not in a newspaper.”</p><p> 当被问及为什么阿斯利康与华尔街分析师以及其他一些官员和专家共享一些信息，而不与公众共享时，他回答说：“我认为反映结果的最佳方法是在同行评审的科学期刊上，而不是在报纸上。”</p><p> AstraZeneca was the third company this month to report encouraging early results on a coronavirus vaccine candidate. At first glance on Monday morning, the results looked promising. Depending on the strength at which the doses were given, the vaccine appeared to be either 90 percent or 62 percent effective. The average efficacy, the developers said, was 70 percent.</p><p> 阿斯利康是本月第三家报告令人鼓舞的关于冠状病毒疫苗候选药物的令人鼓舞的早期结果的公司。乍一看，星期一的结果看起来很有希望。根据剂量的强弱，疫苗似乎有效率为90％或62％。开发人员说，平均功效为70％。</p><p>  The regimen that appeared to be 90 percent effective was based on participants receiving a half dose of the vaccine followed a month later by a full dose; the less effective version involved a pair of full doses. AstraZeneca disclosed in its initial announcement that fewer than 2,800 participants received the smaller dosing regimen, compared with nearly 8,900 participants who received two full doses.</p><p>  似乎有90％的有效性的方案是基于参与者接受了一半剂量的疫苗，而一个月后又接受了全剂量；效果较差的版本需要一对完整剂量。阿斯利康（AstraZeneca）在其最初的公告中披露，接受较小剂量方案的参与者少于2800人，而接受两次全剂量的近8900名参与者。</p><p> The biggest questions were, why was there such a large variation in the effectiveness of the vaccine at different doses, and why did a smaller dose appear to produce much better results? AstraZeneca and Oxford researchers said they did not know.</p><p> 最大的问题是，为什么不同剂量的疫苗效力会有如此大的差异，为什么较小的剂量似乎会产生更好的效果？阿斯利康和牛津大学的研究人员说，他们不知道。</p><p> Crucial information was also missing. The company said that the early analysis was based on 131 symptomatic Covid-19 cases that had turned up in study participants. But it did not break down how many cases were found in each group of participants — those who received the half-strength initial dose, the regular-strength initial dose and the placebo.</p><p> 重要信息也丢失了。该公司表示，早期分析是基于131例有症状的Covid-19病例，这些病例在研究参与者中出现。但这并没有细分每组参与者中发现了多少病例-那些接受了半强度初始剂量，常规强度初始剂量和安慰剂的患者。</p><p> “The press release raised more questions than it answered,” said John Moore, a professor of microbiology and immunology at Weill Cornell Medical College.</p><p> 威尔·康奈尔医学院的微生物学和免疫学教授约翰·摩尔说：“新闻稿提出的问题多于回答的问题。”</p><p>  Adding to the confusion, AstraZeneca pooled the results from two differently designed clinical trials in Britain and Brazil, a break from standard practice in reporting the results of drug and vaccine trials.</p><p>更令人困惑的是，阿斯利康在英国和巴西汇总了两项设计不同的临床试验的结果，这与报告药物和疫苗试验结果的标准做法有所不同。</p><p> “I just can’t figure out where all the information is coming from and how it’s combining together,” said Natalie Dean, a biostatistician and an expert in vaccine trial design at the University of Florida. She  wrote on Twitter that AstraZeneca and Oxford “get a poor grade for transparency and rigor when it comes to the vaccine trial results they have reported.”</p><p> 佛罗里达大学生物统计学家，疫苗试验设计专家娜塔莉·迪恩（Natalie Dean）说：“我只是无法弄清所有信息的来源以及如何将它们组合在一起。”她在推特上写道，阿斯利康和牛津大学“在他们报告的疫苗试验结果方面，在透明度和严谨性上都差强人意。”</p><p> With AstraZeneca’s shares declining on Monday, company executives held several private conference calls with industry analysts in which they disclosed details that were not in the public announcement, including how the Covid-19 cases broke down across different groups. Such disclosures to analysts are not uncommon in the industry, but they often generate criticism about why the details were not shared with the public.</p><p> 随着阿斯利康股价周一下跌，公司高管与行业分析师举行了数次私人电话会议，他们披露了未公开发布的细节，包括Covid-19案如何在不同群体中分解。这种向分析师披露的信息在行业中并不罕见，但是它们经常引起人们对为什么不与公​​众共享细节的批评。</p><p>  Mr. Pangalos  told Reuters on Monday that the company had not intended for any participants to receive the half dose. British researchers running the trial there had meant to give the full dose initially to volunteers, but a miscalculation meant they were mistakenly given only a half dose. Mr. Pangalos described the error as “serendipity,” allowing researchers to stumble onto a more promising dosing regimen.</p><p>  潘加洛斯先生周一对路透社说，该公司无意让任何参与者都接受一半剂量。在那里进行试验的英国研究人员原本打算将全部剂量提供给志愿者，但计算错误意味着他们被错误地只给予了一半剂量。潘加洛斯先生将该错误描述为“偶然性”，使研究人员偶然发现了一种更有希望的给药方案。</p><p> To many outside experts, that undercut the credibility of the results because the closely calibrated clinical trials had not been designed to test how well a half-strength initial dose worked.</p><p> 对于许多外部专家而言，这削弱了结果的可信度，因为尚未进行严格校准的临床试验来测试半强度初始剂量的效果。</p><p> The company’s initial announcement didn’t mention the accidental nature of the discovery.</p><p> 该公司的最初公告并未提及这项发现的偶然性质。</p><p> “The reality is, it could end up being quite a useful mistake,” Mr. Pangalos said in the interview with The New York Times on Wednesday. “It wasn’t putting anyone in danger. It was a dosing error. Everyone was moving very fast. We corrected the mistake and continued on with the study, with no changes to the study, and agreed with the regulator to include those patients in the analysis of the study as well.”</p><p> 潘加洛斯在周三接受《纽约时报》采访时说：“现实是，这最终可能是一个非常有用的错误。” “这并没有使任何人处于危险之中。这是一个加料错误。每个人的动作都非常快。我们改正了错误，继续进行了研究，没有对研究进行任何更改，并与监管机构达成了一致，也将这些患者也纳入了研究分析中。”</p><p> He added, “It actually doesn’t matter whether it was done on purpose or not.”</p><p>他补充说：“实际上是否有意完成并不重要。”</p><p> In the statement attributed to Oxford, Ms. Meixell, the AstraZeneca spokeswoman, said the error stemmed from an issue, which has since been fixed, with how some of the vaccine doses were manufactured.</p><p> 阿斯利康女发言人迈克塞尔在给牛津大学的声明中说，错误源于一个问题，此问题已得到解决，该问题涉及一些疫苗剂量的生产方法。</p><p> Then, on Tuesday, Moncef Slaoui, the head of Operation Warp Speed, the U.S. initiative to fast-track coronavirus vaccines, noted another limitation in AstraZeneca’s data. On a call with reporters, he suggested that the participants who received the half-strength initial dose had been 55 years old or younger.</p><p> 然后，在星期二，美国快速追踪冠状病毒疫苗的行动“行动速度”行动负责人蒙西夫·斯劳伊（Moncef Slaoui）指出了阿斯利康数据的另一个局限性。在与记者的电话中，他建议接受半强度初始剂量的参与者年龄在55岁以下。</p><p> Mr. Pangalos confirmed that on Wednesday, saying the participants received the half-strength dose over a matter of weeks before the error was discovered.</p><p> 潘加洛斯先生在星期三证实了这一点，称参与者在发现错误之前的几周内接受了半强度剂量。</p><p> The fact that the initial half-strength dose wasn’t tested in older participants, who are especially vulnerable to Covid-19, could undermine AstraZeneca’s case to regulators that the vaccine should be authorized for emergency use.</p><p> 最初的半强度剂量没有在年龄较大的参与者中进行测试，而这些参与者特别容易受到Covid-19的伤害，这可能会破坏阿斯利康向监管机构提出的疫苗应获得紧急使用授权的理由。</p><p> Confused by the all technical terms used to describe how vaccines work and are investigated? Let us help:</p><p> 被用于描述疫苗如何工作和进行研究的所有技术术语所混淆？让我们来帮助：</p><p> Adverse event: A health problem that crops up in volunteers in a clinical trial of a vaccine or a drug. An adverse event isn’t always caused by the treatment tested in the trial.</p><p> 不良事件：在疫苗或药物的临床试验中，志愿者中出现的健康问题。不良事件并不总是由试验中测试的治疗引起的。</p><p> Antibody: A protein produced by the immune system that can attach to a pathogen such as the coronavirus and stop it from infecting cells.</p><p>抗体：免疫系统产生的一种蛋白质，可以附着在冠状病毒等病原体上并阻止其感染细胞。</p><p> Approval, licensure and emergency use authorization: Drugs, vaccines and medical devices cannot be sold in the United States without gaining  approval from the Food and Drug Administration, also known as  licensure. After a company submits the results of  clinical trials to the F.D.A. for consideration, the agency decides whether the product is safe and effective, a process that generally takes many months. If the country is facing an emergency — like a pandemic — a company may apply instead for an  emergency use authorization, which can be granted considerably faster.</p><p> 批准，许可和紧急使用许可：未经美国食品和药物管理局（FDA）的许可，不得在美国出售药品，疫苗和医疗器械。公司向F.D.A提交临床试验结果后。为了进行考虑，该机构决定产品是否安全有效，这一过程通常需要几个月的时间。如果该国正面临紧急情况（例如大流行病），则公司可以代替申请紧急使用授权，这可以更快地获得批准。</p><p> Background rate: How often a health problem, known as an adverse event, arises in the general population. To determine if a vaccine or a drug is safe, researchers compare the rate of adverse events in a trial to the background rate.</p><p> 背景发生率：一般人群中出现健康问题（称为不良事件）的频率。为了确定疫苗或药物是否安全，研究人员将试验中不良事件的发生率与背景发生率进行了比较。</p><p> Efficacy: A measurement of how effective a treatment was in a clinical trial.  To test a coronavirus vaccine, for instance, researchers compare how many people in the vaccinated and placebo groups get Covid-19. The real-world effectiveness of a vaccine may turn out to be different from its efficacy in a trial.</p><p> 功效：衡量一项临床试验中治疗效果的有效程度。例如，为了测试冠状病毒疫苗，研究人员比较了接种疫苗和安慰剂组中有多少人接种了Covid-19。疫苗的实际效果可能与试验中的效果不同。</p><p> Phase 1, 2, and 3 trials: Clinical trials typically take place in three stages. Phase 1 trials usually involve a few dozen people and are designed to observe whether a vaccine or drug is safe. Phase 2 trials, involving hundreds of people, allow researchers to try out different doses and gather more measurements about the vaccine’s effects on the immune system. Phase 3 trials, involving thousands or tens of thousands of volunteers, determine the safety and efficacy of the vaccine or drug by waiting to see how many people are protected from the disease it’s designed to fight.</p><p> 1、2和3期临床试验：临床试验通常分为三个阶段。 1期试验通常需要数十人参加，旨在观察疫苗或药物是否安全。涉及数百人的2期试验使研究人员可以尝试不同的剂量，并收集有关该疫苗对免疫系统影响的更多测量数据。涉及成千上万名志愿者的3期试验通过等待观察有多少人受到保护以免受其设计要对抗的疾病的侵害，来确定疫苗或药物的安全性和有效性。</p><p> Placebo: A substance that has no therapeutic effect, often used in a clinical trial. To see if a vaccine can prevent Covid-19, for example, researchers may inject the vaccine into half of their volunteers, while the other half get a placebo of salt water. They can then compare how many people in each group get infected.</p><p> 安慰剂：一种无治疗作用的物质，通常在临床试验中使用。例如，要查看疫苗是否可以预防Covid-19，研究人员可以将疫苗注射到一半的志愿者中，另一半则注射盐水的安慰剂。然后，他们可以比较每个组中有多少人被感染。</p><p> Post-market surveillance: The monitoring that takes place after a vaccine or drug has been approved and is regularly prescribed by doctors. This surveillance typically confirms that the treatment is safe. On rare occasions, it detects side effects in certain groups of people that were missed during clinical trials.</p><p> 上市后监视：在疫苗或药物获得批准并由医生定期开具之后进行的监视。这种监视通常确认该治疗是安全的。在极少数情况下，它可以检测某些在临床试验中遗漏的人群的副作用。</p><p> Preclinical research: Studies that take place before the start of a clinical trial, typically involving experiments where a treatment is tested on cells or in animals.</p><p>临床前研究：在临床试验开始之前进行的研究，通常涉及对细胞或动物进行治疗测试的实验。</p><p> Viral vector vaccines: A type of vaccine that uses a harmless virus to chauffeur immune-system-stimulating ingredients into the human body. Viral vectors are used in several experimental Covid-19 vaccines, including those developed by  AstraZeneca and  Johnson &amp; Johnson. Both of these companies are using a common cold virus called an adenovirus as their vector. The adenovirus carries coronavirus genes.</p><p> 病毒载体疫苗：一种疫苗，它使用无害的病毒将专职的免疫系统刺激成分引入人体。病毒载体已用于几种实验性Covid-19疫苗中，包括由阿斯利康和强生公司开发的那些疫苗。这两家公司都使用一种称为腺病毒的普通感冒病毒作为其载体。腺病毒携带冠状病毒基因。</p><p> Stephanie Caccomo, a spokeswoman for the Food and Drug Administration, declined to comment on whether the dosing error would hurt the vaccine’s chances of being authorized. The F.D.A. has said it expects vaccines to be at least 50 percent effective in preventing or reducing the severity of the disease, a bar that the vaccine appears to have cleared even in the group that got the two full doses.</p><p> 美国食品和药物管理局发言人斯蒂芬妮·卡科莫（Stephanie Caccomo）拒绝评论剂量错误是否会损害疫苗被批准的机会。 F.D.A.曾表示，预计疫苗在预防或减轻疾病严重程度方面至少有50％的有效率，即使在接种两次全剂量疫苗的人群中，疫苗似乎也已清除了这一标准。</p><p> AstraZeneca’s shares have fallen about 5 percent this week, while broader stock indexes have climbed to record highs. Investors seem to be disappointed with the murky results, especially compared with the much clearer data released by two of AstraZeneca’s chief rivals in the race for a coronavirus vaccine.</p><p> 阿斯利康的股价本周下跌了约5％，而更广泛的股指已经攀升至历史新高。投资者似乎对业绩不佳感到失望，尤其是与阿斯利康的两家主要竞争对手在冠状病毒疫苗竞赛中公布的更为清晰的数据相比。</p><p> Pfizer and Moderna said this month that their vaccines, which use a technology known as “messenger RNA,” appear to be about 95 percent effective. Both offerings seem nearly certain to win emergency authorization from the F.D.A. in the coming weeks.</p><p> 辉瑞公司和摩德纳公司本月表示，他们的疫苗使用了一种称为“信使RNA”的技术，似乎具有约95％的有效率。两种产品似乎都可以肯定会获得美国联邦紧急事务管理局的紧急授权。在未来几周内。</p><p> The AstraZeneca vaccine, which uses a different approach involving a chimpanzee virus to provoke an immune response to the coronavirus, had all the hallmarks of a blockbuster.</p><p> 阿斯利康疫苗使用了另一种涉及黑猩猩病毒的方法来激发对冠状病毒的免疫反应，具有所有标志性的特征。</p><p> It was inexpensive — only a few dollars per dose — and easy to mass-produce. Unlike Pfizer and Moderna’s vaccines, AstraZeneca’s could be stored for months in normal refrigerators. The company has estimated it will be able to produce some three billion doses next year, enough to vaccinate nearly one-fifth of the global population.</p><p> 它价格便宜，每剂仅几美元，而且易于批量生产。与辉瑞和Moderna的疫苗不同，阿斯利康的疫苗可以在普通冰箱中存放数月。该公司估计明年将能够生产约30亿剂疫苗，足以为全球近五分之一的人口提供疫苗。</p><p> Compared to most of the other leading Covid-19 vaccine developers, AstraZeneca is inexperienced when it comes to vaccines. And even before the chaotic release of results, the company was under scrutiny for its handling of the testing process.</p><p>与大多数其他领先的Covid-19疫苗开发商相比，阿斯利康在疫苗方面经验不足。甚至在混乱的结果发布之前，该公司就其测试过程的处理都受到了审查。</p><p> In September, AstraZeneca paused clinical trials worldwide after a participant fell ill — but the company didn’t promptly announce the decision publicly. AstraZeneca also came under fire for providing details about the nature of the illness on a private conference call with investors hosted by the investment bank J.P. Morgan, rather than disseminating the information to the public. Both of those developments were first  reported by STAT, which covers health and science news.</p><p> 参与者患病后，9月，阿斯利康（AstraZeneca）在世界范围内暂停了临床试验-但该公司没有立即公开宣布这一决定。阿斯利康还因在与投资银行摩根大通（J.P. Morgan）主持的投资者举行的私人电话会议上提供有关疾病性质的详细信息而备受抨击，而不是向公众传播这些信息。 STAT首次报道了这两项进展，报道了健康和科学新闻。</p><p> Ever since the Oxford-AstraZeneca team emerged as front-runners in the race to develop a vaccine this spring, Prime Minister Boris Johnson of Britain has embraced the effort. The government preordered 100 million doses and cast the research as one of the country’s most important contributions to fighting the pandemic.</p><p> 自从牛津-阿斯利康团队在今年春季开发疫苗的竞赛中脱颖而出以来，英国首相鲍里斯·约翰逊就一直在努力。政府预先订购了1亿剂疫苗，并将这项研究视为该国对抗大流行病最重要的贡献之一。</p><p> Basking in the results on Monday, Mr. Johnson said the vaccine “has the makings of a wonderful British scientific achievement.”</p><p> 约翰逊周一表示，该疫苗“具有英国出色的科学成就。”</p><p> In the United States, which has ordered at least 300 million doses of AstraZeneca’s vaccine, the regulatory path forward is unclear. AstraZeneca was circumspect on Monday about its plans for seeking regulatory approval. The company said it would seek guidance from the Food and Drug Administration on whether it should formally submit its findings to apply for emergency authorization.</p><p> 在已经订购了至少3亿剂阿斯利康疫苗的美国，监管的前进方向尚不清楚。周一，阿斯利康对寻求监管批准的计划持谨慎态度。该公司表示，将就是否应正式提交调查结果以申请紧急授权而向食品药品监督管理局寻求指导。</p><p> AstraZeneca has not been testing the promising half-strength initial dose in its ongoing United States trial. The company said it would work with the agency to add it as quickly as possible to that trial.</p><p> 阿斯利康尚未在其正在进行的美国试验中测试有希望的半强度初始剂量。该公司表示，将与该机构合作，将其尽快添加到该试验中。</p><p> Mr. Pangalos said the company is planning a global trial to compare the two dosing regimens. The number of participants it will enroll hasn’t yet been determined, but it will be in the thousands.</p><p> Pangalos先生说，该公司正计划进行一项全球试验，以比较这两种给药方案。尚未确定参加人数，但将是成千上万。</p><p>  “The only way they’re going to find out is by specifically and deliberately testing this serendipitous observation,” Professor Moore said. “The onus is on them to prove the speculation.”</p><p>摩尔教授说：“他们唯一能找到的方法就是特意测试这种偶然发现。” “他们有责任证明这种猜测。”</p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.nytimes.com/2020/11/25/business/coronavirus-vaccine-astrazeneca-oxford.html">https://www.nytimes.com/2020/11/25/business/coronavirus-vaccine-astrazeneca-oxford.html</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/面临/">#面临</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/mistake/">#mistake</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/疫苗/">#疫苗</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>